SH – Apollon Formularies Plc Related Content
The importance of personalised medicine & technology in the future of medical cannabis
Dr Stephen Barnhill M.D from Apollon Formularies Plc discusses the potential for technology to upgrade personalised medicine for cannabis treatments.
Medical cannabis & the future of cancer treatments
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
